Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Women's Health Med Quizzes > Med Quiz III > Flashcards

Med Quiz III Flashcards

1
Q

clomiphene citrate: classification

A

ovarian stimulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

clomiphene citrate: indication

A
  • female fertility in which estrogen levels are normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clomiphene citrate: contraindications

A
  • pregnancy
  • liver disease
  • abnormal bleeding of undetermined origin
  • ovarian cysts
  • neoplastic disease
  • therapy is ineffective in women with ovarian or pituitary failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clomiphene citrate: ADRs

A
  • ovarian enlargement
  • symptoms similar to PMS
  • ovarian hyperstimulation syndrome
  • multiple gestation
  • visual disturbances
  • abdominal distention
  • discomfort
  • n/v
  • abnormal uterine bleeding
  • breast tenderness
  • insomnia, nervousness, HA< depression, fatigue, lightheadedness, dizziness
  • hot flashes
  • inc urinartion
  • allergic symptoms
  • dry cervical mucous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clomiphene citrate: nursing considerations

A
  • take hx to determine if woman has a hx of liver dysfunction or abnormal uterine bleeding
  • rule out possibility of pregnancy
  • teach women to report abdominal distention, pain the pelvis, visual disturbances
  • avoid tasks that require mental alertness or coordination b/c the drug can cause lightheadedness, dizziness, visual disturbances
  • stop taking if suspect pregnancy
  • teach that S/S of PMS may occur, but hese are temporary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hepatitis B vaccine: classification

A

vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hepatitis B vaccine: indications

A
  • prevention of hepatitis B in exposed and unexposed infants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hepatitis B vaccine: how is it given normally

A
  • first dose: can be given before infant leaves hospital or at first neonatal appointment
  • second dose: 1-2 mos
  • third dose: 6-18 mos (at least 16 weeks after 2nd dose)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hepatitis B vaccine: how is it given is mother is hep B positive or has an unknown status

A
  • give vaccine w/in 12 hours of birth
    • give along with hepatitis B immune globulin
  • follow normal course for the rest of the series
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hepatitis B vaccine: contraindications

A
  • hypersensitivity to yeast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hepatitis B vaccine: ADRs

A
  • pain or redness at site
  • fever
  • fatigue
  • HA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hepatitis B vaccine: nursing considerations

A
  • if vial is used, shake the solution well before preparing
  • give vaccine w/in 12 hours of birth to an infant of an infected mother
  • do not give IV or ID
  • obtain parental consent before administering
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hepatitis B immune globulin (HBIG): classification

A

immune globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hepatitis B Immune Globulin: indications

A
  • prophylaxis for infants of hepatitis B surface antigen positive mothers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hepatitis B immune globulin: contraindications

A

none known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hepatitis B immune globulin: ADRs

A
  • pain and tenderness at the site
  • urticaria
  • anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hepatitis B immune globulin: nursing considerations

A
  • do not shake or give IV
  • hepatitis vaccine series should begin w/in 12 hours of birth
  • give injection of vaccine and immune globulin at separate sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

vitamin K (phytonadione): classification

A
  • fat soluble vitamin
  • antihemorrhagic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

vitamin K: indication

A
  • prevention or tx of vitamin K deficiency bleeding (hemorrhagic disease of the newborn)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

vitamin K: ADRs

A
  • erythema, pain, and edema at injection site
  • anaphylaxis
  • hemolysis
  • hyperbilirubinemia, especially in a preterm infant or when a large dose is used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

vitamin K: nursing considerations

A
  • protect drug from light until just before administration to prevent decomposition and loss of potency
  • observe all infants for signs of vitamin K deficiency (ecchymoses or bleeding from any site)
  • check that the infant has vitamin K before circumcision
22
Q

erythromycin ophthalmic ointment: classification

A

antibiotic

23
Q

erythromycin ophthalmic ointment: indications

A
  • prophylaxis against gonorrhea
    • helps prevent ophthalmia neonatorium in infants of mothers infected with gonorrhea
  • required by law for all infants, even if mother is not known to be infected
24
Q

erythromycin ophthalmic ointment: ADRs

A
  • burning, itching, irritation may result in chemical conjunctivitis lasting 24-48 hours
  • may cause temporary blurred vision
25
Q

erythromycin ophthalmic ointment: nursing considerations

A
  • do not rinse
  • ointment may be wiped from outer eye after 1 minute
  • observe for irritation
26
Q

pertussis vaccine: classification

A

vaccine

27
Q

pertussis vaccine: indication

A
  • recommended for all adults in contact with infants to prevent whopping cough in the infants
    • may be offered to women during pregnancy or before hospital discharge after childbirth
  • usually given with tetanus and diptheria vaccines (Tdap)
28
Q

pertussis vaccine: ADRs

A
  • Abdominal pain,
  • arthralgia,
  • chills,
  • diarrhea,
  • fatigue,
  • headache,
  • myalgia,
  • n/v
  • pain at injection site
29
Q

pertussis vaccine: contraindications

A
  • anaphylactic rxn after a previous dose of Tdap vaccine
30
Q

pertussis vaccine: nursing considerations

A
  • administer IM
  • preferably given during weeks 27-36 gestation
31
Q

rubella vaccine: classification

A

attentuated live virus vaccine

32
Q

rubella vaccine: indications for childbearing women

A
  • administered at least 28 days before pregnancy or after childbirth/abortion to women whose antibody screen shows they are not immune to rubella
  • prevents rubella infection and possible severe congenital defects in the fetus during a subsequent pregnancy
33
Q

rubella vaccine: contraindications

A
  • women who are: immunosuppressed, pregnant, sensitive to vaccine components, or have severe illness
  • should be tested for immune status at 6-8 weeks to be sure that they are immune
34
Q

rubella vaccine: ADRs

A
  • transient stinging at site
  • fever
  • lymphadenopathy
  • arthralgia
  • transient arthritis
35
Q

rubella vaccine: nursing considerations

A
  • vials should be refridgerated
  • reconstitute only w/ diluent dupplied w/ vial
  • use immediately after reconstitution and discard if not used w/in 8 hours
  • protect from light
  • check with HCP before giving near time of administration of RhoGAM
  • avoid pregnancy for at least 28 days (4 weeks) after vaccination
36
Q

Rho(D) Immune Globulin: classification

A
  • concentrated immunoglobulins directed toward the RBC antigen Rho(D)
37
Q

Rho(D) Immune Globulin: indications

A
  • administered to Rh-negative women who have been exposed to Rh-positive blood by doing the following:
    • delivering an Rh-positive infant
    • aborting an Rh-positive infant
    • undergoing chorionic villous sampling, amniocentesis, or intraabdominal trauma while carrying an Rh-positive infant
    • receiving inadvertent transfusion of Rh-positive blood
38
Q

Rho(D) Immune Globulin: contraindications

A
  • women who are Rh-positive or who were previously sensitized to Rho(D) should not receive
39
Q

Rho(D) Immune Globulin: ADRs

A
  • local pain at IM site
  • fever
40
Q

Rho(D) Immune Globulin: Nursing considerations

A
  • administer w/in 72 of childbirth
  • type and antibody screening of the mother’s blood and cord blood type of the newborn to determine need for the medication
    • the mother must be Rh-neg and negative for Rh antibodies
    • the newborn must be Rh positive
  • if fetal blood type after termination is unknown, the medication should be administered
  • newborn may have a weakly positive antibody test if the woman received Rho(D) Immune Globulin during pregnancy
  • administer IM in the deltoid
41
Q

varicella vaccine: classification

A

live vaccine

42
Q

varicella vaccine: indication

A
  • chickenpox in pregnant women can cause infection and complications in the fetus/newborn
    • recommended that women who are not immune to varicella should receive the first dose of varicella vaccine after delivery and before discharge
    • do not become pregnant for 1 month after receiving vaccine
43
Q

varicella vaccine: contraindications

A
  • anaphylactic rxn after previous dose
  • immunosuppression
  • pregnancy
44
Q

varicella vaccine: ADRs

A
  • Fever,
  • pain at injection site.
  • Immunosuppression may ↓ antibody response to injection and ↑ the risk of viral transmission
45
Q

varicella vaccine: nursing considerations

A
  • should not become pregnant for 1 month after receiving vaccine
  • administer subQ
46
Q

Sweet Ease: classification

A

sucrose analgesia

47
Q

Sweet Ease: indication

A
  • used to decrease pain during painful or stressful procedures
    • heel stick, venipuncture, IV insertion, injections, eye exams, suturing, circumcisions
  • can decrease crying, grimacing, HR and pain
48
Q

Sweet Ease: contraindications

A
  • less than 32 weeks gestation
  • critical illness
  • confirmed or suspected GI pathology for necrotizing enterocolitis, cardiac lesions, hx of asphixia, feeding intolerance, lack of bowel sounds
  • preop sedated patients
  • paralyzed infants
49
Q

Sweet Ease: ADRs

A
  • slight transient desauration
  • hyperglycemia
  • gagging, choking
50
Q

Sweet Ease: nursing considerations

A
  • analgesic effects of sucrose can be maximized if given with a pacifier
  • do not give if less than 32 weeks gestation
  • only give PO: should receive no more than 1 mL/day
  • if given for circumcision, patient should also receive other forms of pain relief

Women's Health Med Quizzes (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions